PATENT CLAIM ANALYSIS

Application Number: 15910830
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "414000"]

Abstract:
The invention relates to (among other things) polymer-semaxanib moiety conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over the semaxanib moiety in unconjugated form.

Claim (Index 3):
The compound of  claim 1 , encompassed by the formula: wherein:\n R 1  is either H or halo; \n R 2  is selected from the group consisting of H, halo, NO 2  and lower alkyl; \n R 3  is either H or lower alkyl; \n R 4  is selected from the group consisting of H, halo, lower alkyl and CH 2 CH 2 COOH; \n R 5  is selected from the group consisting of H, lower alkyl, COOH, CH 2 CH 2 COOCH 3  and COOCH 2 CH 3 ; \n R 6  is selected from the group consisting of H, halo, lower alkyl, \n X is a spacer moiety; and \n POLY 1  is a first water-soluble, non-peptidic oligomer; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.19444
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13995301', '15792060', '13995819', '14336764', '13996834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915838492583837
- 35 USC 102 Novelty (BERT): 0.5367434422889302
- Combined Prediction Score: 0.7660998085614383
- Mean Citation Score: 322.18016
- Max Citation Score: 358.61536
- Similarity Product: 254.48901043548585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test